The ivermectin prescription rate was 1.6% for the top 3 states.
Study suggests medical masks may offer similar protecion as N95 respirators, but experts say hold on.
Public health professionals use some terms imprecisely, others incorrectly, and still others technically accurate but almost sure to be misunderstood by the public.
Get weekly COVD-19 updates in your inbox.
Catch the latest episode!
Top COVID FAQs
By CIDRAP & other experts
Up-to-date COVID-19 data
A Sri Lankan analysis of global COVID-19 intervention measures showed that increased testing had the greatest impact on transmission: a 10-fold increase in the ratio of tests to new cases (TCR) reduced a country's average transmission by 9%. The study authors suggest that intense testing combined with isolation may be the most effective and least costly strategy for controlling COVID-19.
The CDC advises 10 days of quarantine with no symptoms and 7 days if no symptoms and a negative test.
An outbreak of carbapenem-resistant Acinetobacter baumannii happened after some control steps were altered.
The UK becomes the first country in the world to approve a COVID-19 vaccine for emergency use.
A New England Journal of Medicine study yesterday of cancer patients with COVID-19 demonstrated viral RNA shedding for up to 78 days and live virus for up to 61 days, suggesting extended infectiousness in patients whose immune system is suppressed.
The experts also raised the possibility that, for the next phase, essential workers could be placed ahead of seniors and those with underlying conditions as a way to prioritize people of color, who have higher risk.
The pandemic has pushed the number of people needing humanitarian assistance up 40%, a record high.
The number of Americans currently hospitalized for COVID-19 reaches 96,039, up from 93,219 the day before.
The report calls for increased transparency on vaccine and treatment development and meeting states' needs for scarce medical supplies.
A study in Clinical Infectious Diseases yesterday found that 1% of US blood donations late last year and in early 2020 contained SARS-CoV-2 antibodies, suggesting that the virus was present in the United States earlier than previously thought.
SARS-CoV-2, the virus that causes COVID-19, was first recognized in Wuhan, China, in December 2019, and the initial US case was identified on Jan 19.